A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-22
DOI
10.1007/s00415-020-09913-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
- (2019) Ai-Lan Nguyen et al. Multiple Sclerosis and Related Disorders
- Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis
- (2019) Sarah C. MacDonald et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review
- (2019) Patricia K Coyle et al. Multiple Sclerosis and Related Disorders
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
- (2018) Emilio Portaccio et al. NEUROLOGY
- Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era
- (2018) Raed Alroughani et al. NEUROLOGY
- Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS
- (2018) Maria K. Houtchens et al. NEUROLOGY
- Treatment of multiple sclerosis during pregnancy – safety considerations
- (2017) Jan Thöne et al. Expert Opinion On Drug Safety
- Evolving concepts in the treatment of relapsing multiple sclerosis
- (2017) Giancarlo Comi et al. LANCET
- Glatiramer acetate during early pregnancy: A prospective cohort study
- (2016) Sandra Herbstritt et al. Multiple Sclerosis Journal
- Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
- (2016) Sandra Thiel et al. Multiple Sclerosis Journal
- Glatiramer acetate during early pregnancy: A prospective cohort study
- (2016) Sandra Herbstritt et al. Multiple Sclerosis Journal
- Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
- (2016) Sandra Thiel et al. Multiple Sclerosis Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
- (2014) Neda Ebrahimi et al. Multiple Sclerosis Journal
- Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review
- (2012) E. Lu et al. NEUROLOGY
- Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs
- (2011) E Lu et al. Multiple Sclerosis Journal
- Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study
- (2009) C Weber-Schoendorfer et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search